Financhill
Back

Surgery Partners Quote, Financials, Valuation and Earnings

Surgery Partners Price Quote

$24.72
-0.79 (-3.08%)
(Updated: November 14, 2024 at 5:15 PM ET)

Surgery Partners Key Stats

Sell
44
Surgery Partners (SGRY) is a Sell

Day range:
$25.38 - $30.11
52-week range:
$22.25 - $36.92
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.29
P/B ratio:
1.93%

Volume:
2.3M
Avg. volume:
778.2K
1-year change:
-4.48%
Market cap:
$3.8B
Revenue:
$2.7B
EPS:
$-0.27

How Much Does Surgery Partners Make?

Is Surgery Partners Growing As A Company?

  • What Is Surgery Partners's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.14%
  • What Is Surgery Partners's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Surgery Partners Stock Price Performance

  • Did Surgery Partners Stock Go Up Last Month?
    Surgery Partners share price went down by -16.27% last month
  • Did SGRY's Share Price Rise Over The Last Year?
    SGRY share price fell by -4.48% over the past 1 year

What Is Surgery Partners 52-Week High & Low?

Surgery Partners Price To Free Cash Flow

Is It Risky To Buy Surgery Partners?

  • How Much Debt Does Surgery Partners Have?
    Total long term debt quarterly is $3.1B
  • How Much Cash Does Surgery Partners Have?
    Cash and short term investments quarterly total is $213.5M
  • What Is Surgery Partners’s Book Value Per Share?
    Book value per share is 15.36

Is Surgery Partners Cash Flow Positive?

  • What Is SGRY Cash Flow From Operations?
    Cash flow from operations (TTM) is $290.7M
  • What Is Surgery Partners’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $156.3M
  • What Is Surgery Partners’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$410.9M

Surgery Partners Return On Invested Capital

  • Is Management Doing A Good Job?
    SGRY return on invested capital is -0.55%
  • What Is Surgery Partners Return On Assets?
    ROA measures how assets are converting to revenues and is -0.49%
  • What Is SGRY Return On Equity?
    ROE is a measure of profitability and is -1%

Surgery Partners Earnings Date & Stock Price

Surgery Partners Competitors

  • Who Are Surgery Partners's Competitors?
    Below is a list of companies who compete with Surgery Partners or are related in some way:
    • DaVita Inc (DVA)
    • Encompass Health Corp (EHC)
    • Healthcare Services Group Inc (HCSG)
    • Kindly MD Inc (KDLY)
    • The Oncology Institute Inc (TOI)

Surgery Partners Dividend Yield

Surgery Partners Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -27.17%
Revenue: 14.16% 0.08%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 39.44
Upside from Last Price: 54.62%

Major Shareholders

  • How many SGRY shares are owned by institutional investors?
    264.4M SGRY shares are owned by institutional investors
  • How many SGRY shares are owned by insiders?
    5.4M SGRY shares are owned by insiders